Related Experiment Video

Updated: Aug 17, 2026

The Goeckerman Regimen for the Treatment of Moderate to Severe Psoriasis
11:39

The Goeckerman Regimen for the Treatment of Moderate to Severe Psoriasis

Published on: July 11, 2013

Isotretinoin treatment of pityriasis rubra pilaris

C H Dicken

    Journal of the American Academy of Dermatology
    |February 1, 1987
    PubMed

    Abstract:

    Five patients with pityriasis rubra pilaris were treated with isotretinoin from September 1982 through 1985. Isotretinoin at an average dose of 1.16 mg/kg/day for 16 to 24 weeks caused complete or almost complete clearing in four of the five patients.

    More Related Videos

    Using a 1064-nm Picosecond Neodymium-Doped Yttrium Aluminum Garnet Laser for Periorbital Hyperpigmentation
    04:43

    Using a 1064-nm Picosecond Neodymium-Doped Yttrium Aluminum Garnet Laser for Periorbital Hyperpigmentation

    Published on: May 23, 2025

    Clinical Application of Intense Pulsed Light Therapy and Radio Frequency for Treatment of Ocular Surface Diseases
    07:36

    Clinical Application of Intense Pulsed Light Therapy and Radio Frequency for Treatment of Ocular Surface Diseases

    Published on: July 3, 2025

    Related Experiment Videos

    Last Updated: Aug 17, 2026

    The Goeckerman Regimen for the Treatment of Moderate to Severe Psoriasis
    11:39

    The Goeckerman Regimen for the Treatment of Moderate to Severe Psoriasis

    Published on: July 11, 2013

    Using a 1064-nm Picosecond Neodymium-Doped Yttrium Aluminum Garnet Laser for Periorbital Hyperpigmentation
    04:43

    Using a 1064-nm Picosecond Neodymium-Doped Yttrium Aluminum Garnet Laser for Periorbital Hyperpigmentation

    Published on: May 23, 2025

    Clinical Application of Intense Pulsed Light Therapy and Radio Frequency for Treatment of Ocular Surface Diseases
    07:36

    Clinical Application of Intense Pulsed Light Therapy and Radio Frequency for Treatment of Ocular Surface Diseases

    Published on: July 3, 2025

    Related Concept Videos

    Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists01:23

    Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists

    Prostacyclin receptor agonists are a class of therapeutic agents integral to managing pulmonary arterial hypertension (PAH). These drugs operate by mimicking the action of prostaglandin I2, or PGI2, a naturally occurring compound in the body.
    These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
    Acne Infection01:27

    Acne Infection

    Acne is a multifactorial skin condition primarily affecting adolescents and young adults, with a global prevalence estimated to exceed 75% in this demographic. The condition is characterized by the formation of comedones (blackheads and whiteheads), papules, pustules, nodules, and, in severe cases, cysts, particularly in areas rich in sebaceous glands such as the face, neck, chest, and back. The pathogenesis involves increased sebum production, follicular hyperkeratinization, colonization by...

    Articles linked to this work by shared authors, journal, and citation graph.

    Porphyria cutanea tarda and human immunodeficiency virus: two cases associated with hepatitis C.

    Mayo Clinic proceedings·1998

    Recognizing cutaneous drug eruptions. Reaction patterns provide clues to causes.

    Postgraduate medicine·1998

    Trigeminal trophic syndrome.

    Mayo Clinic proceedings·1997

    Indeterminate cell histiocytosis treated successfully with 2-chlorodeoxyadenosine.

    Cutis·1997

    Pancreatic panniculitis.

    Journal of the American Academy of Dermatology·1995

    Scleromyxedema.

    Journal of the American Academy of Dermatology·1995

    Sonelokimab, a novel IL-17A- and IL-17F-inhibiting nanobody for the treatment of moderate-to-severe hidradenitis suppurativa: a global, randomized, double-blind, placebo-controlled phase 2 clinical trial (MIRA).

    Journal of the American Academy of Dermatology·2026

    Collaborative Multicenter Prognostication and Staging System for Cutaneous Squamous Cell Carcinoma (COMPASS-SCC).

    Journal of the American Academy of Dermatology·2026

    Usefulness of neutrophil-to-lymphocyte ratio in the prognosis of cutaneous squamous cell carcinoma: a single-center retrospective cohort study.

    Journal of the American Academy of Dermatology·2026

    A Clinical Approach to Psychodermatologic Conditions: From Recognition to Treatment.

    Journal of the American Academy of Dermatology·2026

    Stroboscopic visual training in sport: a structured narrative review of effects, applications, and potential neurophysiological mechanisms.

    PeerJ·2026

    External Validation and Comparison of Automated Retinal Image Quality Grading Methods in the Canadian Longitudinal Study on Aging.

    Ophthalmology science·2026

    ZOETROPE: A Decentralized Framework for Licensing Visual Content for Generative AI.

    IEEE computer graphics and applications·2026

    Visual difficulty with internet-enabled devices among older adults with low vision.

    Optometry and vision science : official publication of the American Academy of Optometry·2026

    Spatial Attention and Session Day Jointly Modulate Human Visual Cortical Plasticity.

    The European journal of neuroscience·2026

    Evaluation of iStent® Inject W in mild to moderate primary open-angle glaucoma - Indian data on pseudophakic eyes.

    Indian journal of ophthalmology·2026
    See all related articles
    JoVE
    x logofacebook logolinkedin logoyoutube logo
    ABOUT JoVE
    OverviewLeadershipBlogJoVE Help Center
    AUTHORS
    Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
    LIBRARIANS
    TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
    RESEARCH
    JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
    EDUCATION
    JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
    Terms & Conditions of Use
    Privacy Policy
    Policies
    Jove
    Visualize
    Contact Us